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Cytochrome cFlavonoids can protect cells from different insults that lead to mitochondria-mediated cell death, and
epidemiological data show that some of these compounds attenuate the progression of diseases associated
with oxidative stress and mitochondrial dysfunction. In this work, a screening of 5 ﬂavonoids representing
major subclasses showed that they display different effects on H2O2 production by mitochondria isolated
from rat brain and heart. Quercetin, kaempferol and epicatechin are potent inhibitors of H2O2 production
by mitochondria from both tissues (IC50≈1–2 μM), even when H2O2 production rate was stimulated by
the mitochondrial inhibitors rotenone and antimycin A. Although the rate of oxygen consumption was
unaffected by concentrations up to 10 μM of these ﬂavonoids, quercetin, kaempferol and apigenin inhibited
complex I activity,while up to 100 μMepicatechin produced less than20% inhibition. The extent of this inhibition
was found to be dependent on the concentration of coenzymeQ in themedium, suggesting competition between
the ﬂavonoids and ubiquinone for close binding sites in the complex. In contrast, these ﬂavonoids did not signif-
icantly inhibit the activity of complexes II and III, and did not affect the redox state of complex IV. However, we
have found that epicatechin, quercetin and kaempferol are able to stoichiometrically reduce puriﬁed cytochrome
c. Our results reveal that mitochondria are a plausible main target of ﬂavonoids mediating, at least in part, their
reported preventive actions against oxidative stress and mitochondrial dysfunction-associated pathologies.
© 2011 Elsevier B.V. All rights reserved.1. Introduction
It is widely accepted that mitochondrial production of reactive
oxygen species (ROS) contributes to the detrimental alterations in
the etiology and/or progression of many pathological conditions,
including neurodegeneration, brain and myocardial ischemia–
reperfusion injury, vascular disease and heart failure (for reviews,
see [1–5]).
Production of ROS by mitochondria is stimulated by the types of
inhibition of respiratory chain observed in some cardiac diseases [1]
and in Parkinson's and Huntington's brain [2,6], as well as by several
cellular signaling pathways activated in different degenerativel; DMSO, dimethyl sulfoxide;
lene glycol-bis(2-aminoethyl
entration; ROS, reactive oxygen
ethyl)aminomethane
istry and Molecular Biology,
Badajoz, Spain. Tel./fax: +34
rino).
l rights reserved.processes, e.g. tumor necrosis factor-α, oncogenes, hypoxia and nitric
oxide [7,8].
The complexes I and III of the mitochondrial respiratory chain are
known to be major sources of intracellular superoxide anion [2,9],
and cellular oxidative stress has been shown to mediate the neurode-
generation of critical brain areas observed in ischemia–reperfusion
insults [10,11], inﬂammation [12–14], neurotoxicity of drugs and
environmental chemicals [15–18], and also in Alzheimer, Parkinson
and other neurodegenerative diseases [19–22]. Therefore, substances
or therapies targeting basic mitochondrial processes, such as energy
metabolism or free radical generation hold great promise for disease
prevention and treatment.
Flavonoids are low molecular weight phenolic compounds with a
quinonoid-like chemical structure, which display signiﬁcant ROS
scavenging and metal chelating activities, as well as other cellular
antioxidant actions [23–25]. Because of the implication of ubiqui-
none radicals in mitochondrial ROS production [26], mitochondrial
respiratory chain components can be seen as likely molecular
targets for the cellular antioxidant actions of ﬂavonoids. The data
from dietary bioavailability of ﬂavonoids point out that physiologic
plasma concentrations of total metabolites do not exceed 10 μmol/
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sources, and it has been shown that total ﬂavonoid metabolites
can reach plasma concentrations up to 4.0 μmol/L with an intake
of 50 mg aglycone equivalents, except for isoﬂavones that can
reach higher concentrations [28]. There is substantial evidence
from experiments with animal models that ﬂavonoids can access
the brain. After oral administration several ﬂavonoids have been
detected in rat and mouse brains, like epigallocatechin gallate
and epicatechin metabolites [29,30], quercetin and quercetin
metabolites [31] and anthocyanidins [32,33]. Furthermore, baicalin
has been detected in the rat cerebrospinal ﬂuid after a single i.v.
dose [34], and naringenin and hesperetin have been detected in
several rat brain regions after i.v. administration [35,36]. In addition,
as also observed with other compounds [37], ﬂavonoid access to the
brain tissue can also increase as a result of dysfunction of the blood–
brain barrier, a pathological condition of all neurodegenerative diseases
[38].
Despite that many studies have shown that several ﬂavonoids
display protective activity against oxidative stress-mediated neuronal
cell death, recently reviewed in [39], and that many experimental data
have pointed out the relevance of mitochondria as a source of intracel-
lular ROS, there is a lack of a systematic study on the modulation of
ROS production by brain and heart mitochondria by representative
members of the major types of ﬂavonoids. This point is particularly
timely, as recently published data have pointed out that within the
cells ﬂavonoids can be enriched in mitochondria. Epigallocatechin-3-
gallate has been reported to speciﬁcally accumulate (90–95%) in
the mitochondrial fraction of cerebellar granule neurons in culture,
and it has been proposed that due to this the ﬂavonoid afforded
protection against mitochondrial oxidative stress-associated insults
[40]. Fiorani et al. [41] also measured a considerable accumulation
of quercetin in the mitochondria of Jurkat cells exposed to the ﬂavo-
noid, and suggested that the organelle can represent a reservoir of
biologically active quercetin.
It has been reported that high concentrations (50 μM) of some
ﬂavonoids inhibit the respiration of rat liver mitochondria [42,43],
and more recent works have revealed that quercetin and genistein
modulate the activity of the mitochondrial permeability transition
pore [44–46]. However, this is a controversial issue as it has also
been reported that high concentrations of quercetin (30–50 μM)
can also produce stimulation of oxygen consumption by rat liver
and kidney mitochondria [45,46]. Noteworthy, it has been shown
that the inhibition produced by quercetin and kaempferol is observed
only at relatively high and likely supra-physiological levels of these
ﬂavonoids, since low micromolar concentrations, up to 10 μM of
kaempferol or quercetin, did not inhibit succinate-supported mito-
chondrial respiration [47]. In this regard it is to be recalled here that pre-
vious works have pointed out that quercetin is only a moderate
uncoupler of plant mitochondria based on the small effects of this
ﬂavonoid on the rate of oxygen consumption [48]. Moreover, Santos
et al. have reported a measurable inhibition only for concentrations
of quercetin higher than 25 μM [43]. A similar result has been
recently reported for inhibition of malate/glutamate-supported
respiration of HeLa cells by kaempferol [49]. The effect of 50 μM
quercetin on the production of superoxide by mitochondria from
different tissues is also a controversial topic, i.e. no effect on rat
kidney mitochondria [46] and increase in rat liver mitochondria
[45].
Flavonoids have been shown to protect against oxidative stress-
mediated neuronal death using cultures of primary neurons and
neuronal cell lines [50–52]. The ability of ﬂavonoids to function as
ROS scavengers is related to their capability to form stable radicals,
a property that is shared by aromatic compounds containing o-
dihydroxyl groups or close hydroxyl and carbonyl groups. However,
the potency of ﬂavonoids as cellular antioxidants cannot be accounted
solely in terms of their chemical antioxidant capacity because ofthe lack of correlation between the reduction potential of ﬂavo-
noids and their ability to afford protection against oxidative neu-
ronal death induced by different insults using model neuronal
cultures [39,51,53,54]. Indeed, studies carried out in different lab-
oratories have shown that ﬂavonoids can afford a large inhibition
of cellular ROS production through inhibition of redox enzymes
like NAD(P)H oxidases, xanthine oxidase, monooxygenases,
ciclooxygenases and lipooxygenases, recently reviewed in [39]. It
is to be recalled here that taxifolin (dihydroquercetin) and other
ﬂavonoids at relatively high concentrations, i.e. higher than
100 μM of ﬂavonoid, have been shown to inhibit the peroxidase
activity of the cytochrome c-cardiolipin complex, an activity
linked to the very early stages of apoptosis [55].
In this work we have studied the ability of representative members
of the major classes of ﬂavonoids to attenuate the rate of hydrogen
peroxide production by brain and heart mitochondria. Owing to the
potential therapeutic use of the ﬂavonoids which showed a signiﬁ-
cant inhibition of hydrogen peroxide production by respiring mito-
chondria, we have also studied their effects on the activity and
redox state of major components of the respiratory chain.
2. Materials and methods
2.1. Materials
The ﬂavonoids (−)(−) epicatechin (≥90%), quercetin (>98%),
kaempferol (≥96%), apigenin (≥95%) and naringenin (≥95%) were
obtained from Sigma-Aldrich (Sigma, St. Louis, MO, USA; Aldrich,
Steinhein, Germany). Myricetin (≥95%) was from Fluka. Cyanidin
(>96%) and malvidin (>97%) were obtained from Extrasynthese
SAS (Lyon, France).
Dimethyl sulfoxide (DMSO), sodium chloride, potassium chloride,
magnesium chloride, di-sodium hydrogen phosphate, potassium
dihydrogen phosphate, malic acid and potassium cyanide were sup-
plied by Merck (Darmstadt, Germany). Sodium pyruvate was from
Boehringer Mannheim, Germany.
All other products were obtained from Sigma, unless speciﬁed
otherwise.
2.2. Mitochondria and sub-mitochondrial particles
Wistar rats (~300 g) were sacriﬁced by cervical dislocation and
the brain or heart rapidly excised from each animal and immersed
in cold mitochondria isolation buffer containing sucrose 0.25 M,
EDTA 1 mM and Tris 5 mM (pH 7.4). The brain (without cerebellum)
and the heart were weighted and homogenized in a volume (ml) of
isolation buffer 3 times the weight (g). The homogenate was centri-
fuged at 800 g for 10 min at 4 °C and the supernatant separated and
centrifuged at 12,500 g for 10 min at 4 °C. The mitochondrial pellet
was resuspended in isolation buffer and always kept on ice during
the measurements.
Mitochondrial enzymatic activities were measured with sub-
mitochondrial particles prepared by three freeze–thaw cycles to
disrupt membranes.
Protein concentration in mitochondrial preparations was estimated
using a commercial protein assay kit (Thermo Scientiﬁc, Rockford, IL,
USA) based in Coomassie blue dye and bovine serum albumin as
standard.
2.3. Mitochondrial H2O2 production and oxygen consumption
These measurements were carried out with isolated mitochondria
in respiration buffer containing sucrose 0.25 M, KH2PO4 5 mM, KCl
10 mM, MgCl2 5 mM and Tris 10 mM (pH 7.4), pyruvate 5 mM,
malate 5 mM and ADP 0.2 mM.
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with 0.1 mg/ml mitochondria in respiration buffer supplemented
with horseradish peroxidase 0.2 U/ml and Amplex Red (10-acetyl-
3,7-dihydroxyphenoxazine) 5 μM. The increase in Amplex Red ﬂuo-
rescence was followed at 37 °C using excitation and emission wave-
lengths of 530 and 590 nm, respectively.
Oxygen consumption by mitochondria was measured at 37 °C
with an Oxygraph Plus DW1 (Hansatech Instruments) electrode.
Mitochondria 1 mg/ml in respiration buffer were pre-incubated
with the ﬂavonoids 10 min before addition of pyruvate 5 mM and
malate 5 mM and recording state 4 respiration rate. State 3 respira-
tion rate was measured in the presence of 0.2 mM ADP.
2.4. Enzymatic activities
SOD activity was measured at 37 °C by the method of auto-
oxidation of pyrogallol in 50 mM Tris/HCl, pH 8, with 100 μM
pyrogallol, as in [57]. Auto-oxidation of pyrogallol was monitored
by the increase of absorbance at 420 nm. One unit of SOD activity
is the amount of sample which reduced by 50% the auto-oxidation
rate of 100 μM pyrogallol in 2 ml reaction volume, and the calibra-
tion of the SOD activity of our mitochondrial preparations is
shown in Fig. S1A of Supplementary Data.
Complex I activity of sub-mitochondrial particles was measured as
in [58]. The assay buffer consisted of Tris–HCl 10 mM, KCl 50 mM,
EDTA 1 mM and KCN 2 mM (pH 7.4). The quinone CoQ1 was used as
electron acceptor in a concentration of 50 μM, except when a
different concentration is indicated in the plots. The concentration
of mitochondrial protein used was 20 μg/ml. The reaction was
initiated by the addition of 75 μM NADH and monitored from the
linear decrease of absorbance at 340 nm, at 30 °C. After 2–3 min,
rotenone 5 μg/ml was added to evaluate the activity independent of
rotenone. With the brain and heart mitochondria preparations used
in this work the rotenone-independent activity was always lower
than 10% of the total activity measured. Activities in nmoles per min
per mg mitochondrial protein were calculated using an extinction
coefﬁcient for NADH of 6.23 mM−1 cm−1.
Complex II activity was measured at 30 °C as described in [59].
Sub-mitochondrial particles (5 μg/ml) were suspended in potassium
phosphate buffer 50 mM (pH 7.4) supplemented with succinate
20 mM. After 10 min incubation, 2,6-dichlorophenolindophenol
(DCPIP) 50 μM, rotenone 2 μg/ml, antimycin A 2 μg/ml and KCN 2 mM
were added. The absorbance at 600 nm was recorded for 1 min before
addition of CoQ1 50 μM and, then, the reduction of DCPIP coupled
to complex II-catalyzed reduction of CoQ1 was followed for 3–5 min.
Activities were calculated in nmoles of DCPIP reduced per minute per
mg of protein, using an extinction coefﬁcient for DCPIP of
19.1 mM−1 cm−1.
The coupled activity of complex II plus III was measured from
the rate of ferricyanide reduction in the following medium: sucrose
0.25 M, KH2PO4 5 mM, KCl 10 mM, MgCl2 5 mM and Tris 10 mM
(pH 7.4), i.e. the respiration buffer without substrates described
above, supplemented with succinate 10 mM, potassium ferricyanide
0.8 mM and KCN 0.5 mM. After thermal equilibration at 30 °C, the
reaction was initiated with 100 μg/ml mitochondrial protein and
the change in absorbance at 420 nm was monitored. Activity was
calculated in nmoles of ferricyanide reduced (extinction coefﬁcient
of 1 mM−1 cm−1) per minute per mg of protein.
2.5. Spectroscopic studies: cytochrome c reduction and difference spectra
The changes in the absorption spectra of cytochrome c induced by
ﬂavonoids were studied with solutions of oxidized cytochrome c
(from horse heart) at a concentration of 5 μM in mitochondria isola-
tion buffer without substrates, see above. Absorption spectra of the
solutions were recorded at 37 °C before and at the indicated timeintervals until 30 min after the addition of the ﬂavonoid. Absorption
spectra of the ﬂavonoids in the same buffer were also recorded as
experimental blanks, and found to be negligible above 430 nm.
The kinetics and equilibrium of the reaction between ﬂavonoids
and cytochrome c were studied with solutions of cytochrome c
20 μM in 10 mM potassium phosphate buffer (pH 7.4). Cytochrome
c reduction was followed at 550 nm at 37 °C. Complete reduction of
cytochrome c was achieved by addition of an excess of dithionite
(sodium hydrosulﬁte; Aldrich, Steinhein, Germany).
Absorption difference spectra of mitochondria incubatedwith ﬂavo-
noids were obtained with 2 nm resolution using a Hewlett–Packard
model 8451A diode array spectrophotometer. The diode array spectro-
photometer allows to measure simultaneously the absorbance in the
range of wavelengths selected, making possible to detect spectral
changes associated with coupled redox pairs that show separate ab-
sorption bands. Mitochondria were suspended at a concentration of
0.75 mg/ml in 1 ml of mitochondria isolation buffer (described
above). The suspension was kept under mild stirring for 10 min at
25 °C and the absorption spectrum in the range 400–700 nm was
acquired. In separate assays, it was observed that no additional
changes occurred until 20 min incubation. Then, the ﬂavonoid was
added at a ﬁnal concentration of 20 μM and, after 10 min incubation,
the absorption spectrum of the suspension of mitochondria+ﬂavonoid
was recorded, subtracting the mitochondria spectrum previously
obtained and stored in the diode array spectrophotometer memory.
Absorption spectra of 20 μM ﬂavonoid solutions in the same buffer
were also recorded and subsequently subtracted from the mitochon-
dria spectra to obtain the ﬁnal difference spectra.
3. Results
3.1. Effects of ﬂavonoids on mitochondrial hydrogen peroxide production
and oxygen consumption
It is well established that themitochondrial electron transport chain
produces superoxide (O2−) that is rapidly converted to hydrogen
peroxide (H2O2) by the action of mitochondrial superoxide dismu-
tase, see e.g. [60,61].
We have isolated mitochondria from rat brain and heart and
measured the rate of release of H2O2 using the Amplex Red assay.
This ﬂuorescent probe is highly sensitive for H2O2 [56] and has
been widely used as a reliable, sensitive and robust method to mea-
sure H2O2 generation by mitochondria [9,60,62,63].
Measurements were made with mitochondria suspended in a
sucrose-based respiration buffer containing pyruvate, malate and
ADP, as described in detail in Materials and methods. In these condi-
tions, we observed a slightly higher production rate of H2O2 by heart
compared to brain mitochondria, 0.26±0.02 vs 0.18±0.04 nmol
H2O2/min/mg of mitochondrial protein, respectively.
A group of eight ﬂavonoids representative of the major classes of
these compounds was initially selected for this study and their effects
on mitochondrial H2O2 production was assessed. The group included
ﬂavanols (epicatechin), ﬂavonols (quercetin, kaempferol, myricetin),
ﬂavones (apigenin), ﬂavanones (naringenin) and anthocyanidins
(cyanidin and malvidin). The screening of the response of Amplex
Red/Peroxidase detection system used for H2O2 measurements pointed
out that the ﬂavonoids myricetin, cyanidin and malvidin should be
discarded in these studies, because of their direct interference with
the Amplex Red/Peroxidase detection method (Fig. S2A of Supplemen-
tary Data). However, the increase of the ﬂuorescence of the Amplex
Red/Peroxidase detection system elicited by epicatechin was canceled
by supplementation of the media with 2 mM EGTA (Fig. S2A of Supple-
mentary Data). Thus, the effect of epicatechin on mitochondrial H2O2
production was assayed in the presence of EGTA. The good response
of the Amplex Red/Peroxidase detection system in the presence of
10 μM of the ﬂavonoids apigenin, epicatechin, kaempferol, naringenin,
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increase after addition of different amounts of H2O2. As shown in the
Fig. S2B of Supplementary Data, the response of the detection system
up to 100–200 nMH2O2was not signiﬁcantly affected by the ﬂavonoids
kaempferol, quercetin, apigenin, and naringenin under the routine
conditions used in this work. The small effect of the ﬂavonoid epicate-
chin in presence of EGTA, i.e. a decrease of approx. 10% of the increase
of ﬂuorescence, was taken into account in the calculations of mitochon-
drial H2O2 production. Although it has been reported that ﬂavonoids are
inhibitors of the horseradish peroxidase activity displaying IC50 values
in the micromolar concentration range [64], our results pointed out
that the H2O2 assay is robust enough to function properly most likely
because of the excess of horseradish peroxidase activity used in the
assay medium.
As shown in Fig. 1, the ﬂavonoids showed different effects on the
rate of H2O2 production by mitochondria. Moreover, there were no
indications of transient H2O2 direct-scavenging by ﬂavonoids, i.e. no
signiﬁcant changes of the ﬂuorescence were observed immediately
after the addition of ﬂavonoids. This point was further assessed with
blank experiments (without mitochondria). It is to be noted that the
addition of up to 10 μM ﬂavonoid did not elicit a signiﬁcant change of
the pH, measured to be lower than 0.02 pH units. As also shown in
Fig. 1, there is some variation between the effects of different ﬂavonoids
on H2O2 production rate by brain and heart mitochondria. Quercetin,
kaempferol and epicatechin effectively decreased mitochondrial H2O2
production rate, and kaempferol at a concentration of 10 μM was ableFig. 1. Effects of ﬂavonoids on mitochondrial production of H2O2. (A) Representative exper
addition. Production of H2O2 by mitochondria (0.1 mg/ml) in respiration buffer was detect
experimental traces shown were obtained with rat brain mitochondria and with addition
obtained with rat heart mitochondria. Panels B and C, effects of 1 and 10 μM concentratio
and heart, respectively. (D) Effect of quercetin and kaempferol concentration on H2O2 prod
duction rate relative to the rate observed in the absence of ﬂavonoid, which was taken as co
the controlswere 0.18±0.04 (brain) and 0.26±0.02 (heart). The data represented is themean
mitochondria.to completely block H2O2 release by both brain and heart mitochondria.
Apigenin and naringenin at concentrations of 1 and 10 μM showed no
effects on H2O2 production rate by mitochondria from brain and heart.
On these grounds, we decided to study in more detail the
molecular basis for the inhibition of H2O2 production bymitochondria
afforded by quercerin and kaempferol. In addition, taking into
account that epicatechin and apigenin have been described to have
very potent cytoprotective actions and that they are also representa-
tives of other major ﬂavonoid classes, we decided to examine in more
detail the interaction of these 4 compounds with mitochondria.
The possibility that the decrease of mitochondrial H2O2 production
observed in presence of these ﬂavonoids could be due to inhibition of
mitochondrial SOD activity was assessed by measuring this activity
using pyrogallol. Our results pointed out that at 10 μM the ﬂavonoids
that produce a large inhibition of mitochondrial H2O2 release, i.e.
kaempferol, quercetin and epicatechin, afford at most only 10% inhibi-
tion of mitochondrial SOD activity (see Fig. S1B of Supplementary
Data). This result is in good agreement with the lack of inhibition
of mitochondrial SOD by diphenolic compounds, like catechol and
noradrenaline, and other plant phenols like coumaric acid, ferulic
acid and gentisic acid, reported in [65].
In the screening of ﬂavonoids presented above, quercetin and
kaempferol revealed remarkable abilities to inhibit mitochondrial
H2O2 production. The inhibition curves in Fig. 1D show that these
ﬂavonoids at concentration of 5 μM almost completely abolished
H2O2 production by brain mitochondria. These results yieldedimental traces of oxidation of Amplex Red by mitochondria and the effect of ﬂavonoid
ed by the Amplex Red method as described in the Materials and methods section. The
of 10 μM ﬂavonoid concentration, although it is to be noted that similar traces were
n of ﬂavonoids on the H2O2 production rate of mitochondria isolated from rat brain
uction by rat brain mitochondria. The results are expressed as percentage of H2O2 pro-
ntrol (100% value). The 100% values of H2O2 production rate (in nmol H2O2/min/mg) in
±standard error frommeasurementsmadewith at least three preparations of each type of
Fig. 2. Effects of mitochondrial inhibitors on H2O2 production by mitochondria isolated
from rat heart and brain (A). Production of H2O2 was measured as in Fig. 1. Rotenone,
and antimycin A were used in concentrations 10 μM and 2 μM, respectively. Results are
shown as percentage of H2O2 production rate relative to the production rate observed
with the same mitochondria in the absence of the inhibitors (untreated). The values of
H2O2 production rate of untreated mitochondria (in nmol/min/mg) were 0.26±0.02
(heart) and 0.18±0.04 (brain). Panels B and C represent the capacity of quercetin
and kaempferol to inhibit H2O2 production by brain mitochondria stimulated with
mitochondrial inhibitors. Results are shown as percentage of production rate relative
to the rate observed in the absence of ﬂavonoid, which was normalized to 100%. The
100% values of production rate (in nmol H2O2/min/mg) were 0.18±0.04 (untreated),
0.53±0.09 (rotenone) and 1.50±0.07 (antimycin A). All the results in panels A to C
are the mean±standard error from measurements made with at least three prepara-
tions of each type of mitochondria.
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kaempferol of 1.8 and 0.9 μM, respectively.
The effect of these ﬂavonoids on mitochondrial oxygen consump-
tionwas also assessed. Epicatechin, quercetin, kaempferol and apigenin
up to concentrations of 10 μM showed no signiﬁcant effects on oxygen
consumption rate by mitochondria, neither in state 4 nor in state 3
(Fig. S3 of Supplementary Data). Apigenin was also included as
reference ﬂavonoids, since it did not afford a signiﬁcant inhibition
of the rate of hydrogen peroxide production by respiring mitochondria.
Thus, this result excluded a direct relationship between inhibition of
H2O2 production by these ﬂavonoids and oxygen consumption by
mitochondria.
3.2. Interaction of ﬂavonoids with respiratory chain components
The inhibitors of the respiratory chain rotenone and antimycin
A increased H2O2 production by mitochondria isolated from rat
heart and brain (Fig. 2A), in agreement with the results reported
in other studies [9,60,62].
The ability of quercetin and kaempferol to prevent mitochon-
drial H2O2 production was evaluated with brain mitochondria in
presence of these inhibitors and, as shown in Fig. 2 (B and C),
the potency of the ﬂavonoids was very similar to that observed
against basal H2O2 production of untreated mitochondria.
It is widely accepted that the mitochondrial inhibitors used in
this study amplify mitochondrial H2O2 production by blocking
particular steps of the respiratory chain and increasing electron
leakage to oxygen. The potent capacity of quercetin and kaemp-
ferol to counteract H2O2 production stimulated by the respiratory
chain inhibitors suggested that these ﬂavonoids are likely modu-
lating the electron ﬂow through some component of the electron
transport chain.
3.3. Modulation of complex I by ﬂavonoids
Complex I of the electron transport chain has been reported to be
the main source of superoxide production by mitochondria [9,60,62].
The effect of epicatechin, quercetin, kaempferol and apigenin on
complex I activity of brain sub-mitochondrial particles was studied
and the results are presented in Fig. 3. Complex I activity wasmeasured
as NADH:CoQ1 oxidoreductase activity and it was found that addition of
quercetin, kaempferol and apigenin inhibited enzymatic activity
(Fig. 3A and B). These ﬂavonoids at a concentration of 10 μM produced
approximately 30% inhibition under these experimental conditions
(Fig. 3B). In contrast, 10 μM epicatechin showed a very weak effect on
complex I activity, approximately 10% inhibition. Despite that there
were no indications of an initial lag phase in the inhibition produced
by these ﬂavonoids, in separate experiments, sub-mitochondrial
particles were pre-incubated for 30 min (at 30 °C) with the ﬂavonoids
before assaying the enzymatic activity, and the results obtained were
identical to those shown in Fig. 3B obtained without pre-incubation
with the ﬂavonoid. At higher concentrations, kaempferol exhibited a
more potent inhibitory capacity than quercetin (Fig. 3C). Apigenin at
concentrations up to 10 μM showed an inhibitory potency similar to
kaempferol, but it was not possible to evaluate the effect of higher
concentrations since apigenin caused precipitation of mitochondria in
the assay medium.
As ﬂavonoids have chemical homology with the quinonemoiety of
CoQ, the possibility that ﬂavonoid inhibition could be due to compe-
tition for binding to the quinone binding sites of complex I deserved
to be experimentally tested. The results shown in Fig. 3 were obtained
using 50 μM CoQ1 as electron acceptor for complex I. In a ﬁrst set of
competition experiments, sub-mitochondrial particles were pre-
incubated with CoQ10 before assay of complex I activity with 20 μM
CoQ1, and this led to attenuation of the inhibition by quercetin and
kaempferol (Fig. 4A). Noteworthy, CoQ10 protected more efﬁcientlyagainst the inhibition afforded by quercetin than against the inhibi-
tion produced by kaempferol. It is to be noted that no oxidation of
NADH occurred when CoQ10 was supplied to the assay medium as
the only electron acceptor, conﬁrming that it is not used as Complex
Fig. 3. Effects of ﬂavonoids on complex I activity of rat brain sub-mitochondrial particles.
(A) Representative experimental traces of complex I activity and the effect of ﬂavonoid
addition. Experiments in this ﬁgure were done at 30 °C with mitochondria (20 μg
protein/ml) in the following medium: Tris–HCl 10 mM, KCl 50 mM, EDTA 1 mM, KCN
2 mM and CoQ1 50 μM (pH 7.4). After thermal equilibration of the cuvette containing
mitochondria in the buffer, the reaction was started with NADH and, after approximately
1 min, theﬂavonoidwas added (20 μM in the experiments shown in thisﬁgure). The rapid
increase of absorbance observedwhen the ﬂavonoids were added is due to the absorption
at 340 nm of quercetin and kaempferol. At the end of the assays, rotenone was added to
determine the putative contribution of complex I-independent NADH oxidase activity,
which was lower than 10% of total activity. (B) Inhibition of complex I activity by ﬂavo-
noids at a concentration of 10 μM. (C) Titration of the NADH oxidase activity of complex
I with epicatechin, quercetin, kaempferol and apigenin. The effect of apigenin concentra-
tions higher than 10 μM was not studied, because above 10 μM apigenin induced mito-
chondria precipitation in the assay medium. Inhibition results are presented as
percentage of activity relative to the activity of the same mitochondrial preparation in
the absence ofﬂavonoid and presence of the volume of solvent (DMSO) addedwith theﬂa-
vonoid. The absolute value of the 100% speciﬁc activitywas 179±27 nmolNADHoxidized/
min/mg. The results shown are the mean±standard error of measurements made with 3
to 6 preparations of mitochondria.
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shown, see also [58]). On these grounds, we decided to measure the
inhibitory potency of ﬂavonoids varying the concentration of CoQ1
in the assay medium (Fig. 4B). These results showed that the capacity
of quercetin, kaempferol and apigenin to inhibit complex I decreased
as CoQ1 concentration increased.
3.4. Modulation of other components of the respiratory chain
Complexes II and III also use CoQ10 as substrates and the effect of
the selected ﬂavonoids on the activity of these complexes was inves-
tigated. As illustrated in Fig. S4 of Supplementary Data, epicatechin,
quercetin, kaempferol and apigenin up to concentrations of 10 μM
did not show any signiﬁcant modulation of complex II activity, but
elicited a weak stimulation of the rate of succinate-driven ferricya-
nide reduction produced by mitochondria, i.e. approx. 25% stimula-
tion for quercetin and kaempferol. However, the complex III
speciﬁc activity in the presence of 10 μM of these ﬂavonoids, calcu-
lated from the inhibition afforded by 2 μM antimycin A, was not sig-
niﬁcantly different from the result obtained for the control measured
in the absence of ﬂavonoid, namely 150±15 nmoles/min/mg mito-
chondrial protein.
The assays of the activity of complexes III and IV involve the use
of cytochrome c as substrate [59]. When performing these assays
we noticed that some of the ﬂavonoids altered the reduction state
of the cytochrome c, and this effect could account for the apparentFig. 4. The inhibition of complex I activity of rat brain sub-mitochondrial particles by
ﬂavonoids is antagonized by CoQ10 (A) and CoQ1 (B). Flavonoids (10 μM) were directly
added to the assaymediumof complex I activity in different conditions. In panel A, activity
was measured in presence of 20 μM CoQ1 after incubation of sub-mitochondrial particles
for 20 min at 30 °C with 20 μM CoQ10 in DMSO or with only DMSO (without CoQ10 addi-
tion). In panel B, complex I activity wasmeasuredwith different concentrations of CoQ1 in
assay medium (without any addition of exogenous CoQ10). The results shown are the
mean±standard error from measurements made with three preparations of
mitochondria.
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from the reduction of ferricyanide.
Epicatechin, quercetin and kaempferol readily reduced cyto-
chrome c (Fig. 5). The results obtained with apigenin are not included
in this ﬁgure, because apigenin did not elicit detectable spectral
changes in the solution of cytochrome c. Reduction of the cytochrome
c was established by the spectral changes known to monitor the
reduction of cytochrome c by standard reducing agents like dithionite
(sodium hydrosulﬁte). Addition of the ﬂavonoids to a cytochrome c
solution caused the progressive appearance of distinct absorption
bands at 550 and 520 nm, and the shift of the 410 nm band to slightly
larger wavelengths in the absorption spectrum of the solution, as
shown in Fig. 5A for kaempferol. As illustrated with epicatechin in
Fig. 5B, the kinetics of reaction between the ﬂavonoids and the
cytochrome was concentration dependent.
The study of the stoichiometry of the reduction of cytochrome c by
epicatechin, quercetin and kaempferol pointed to a 2:1 relation
between cytochrome c and ﬂavonoid (Fig. 5C). Thus, each ﬂavonoid
molecule is able to transfer 2 electrons, reducing 2 cytochrome cmol-
ecules. A small fraction of oxidized cytochrome c still remained even
in the presence of an excess of the ﬂavonoids (Fig. 5C). As oxygen re-
moval by gassing the buffer with N2 and later measurements in sealed
cuvettes led to the same result re-oxidation of cytochrome c by the
oxygen dissolved in the solution seemed unlikely. Therefore, these
results lend support to the hypothesis that this is the reduction
level attained at the equilibrium of this redox reaction, and applying
the Nernst equation this will be consistent with a ΔE0′ of 0.046±
0.005 V.
The possibility of interaction of ﬂavonoids with complex IV in mi-
tochondria was explored by spectroscopic methods. Reduction of
complex IV produces a signiﬁcant increase of absorption at 600 nm
[66]. Difference spectra of mitochondria incubated with ﬂavonoid
minus mitochondria pointed out that none of the four ﬂavonoids test-
ed reduced complex IV. Respiringmitochondria incubated with epica-
techin and apigenin did not show well resolved bands in this range
(data not shown).Fig. 5. Reduction of cytochrome c by quercetin, kaempferol and epicatechin. Panel A
shows the changes of the absorption spectrum of cytochrome c elicited by kaempferol.
The ﬂavonoid was added at a ﬁnal concentration of 1 μM to a 5 μM oxidized cytochrome
c solution and the reaction was followed for 30 min. The absorption spectra of 1 μM solu-
tion of kaempferol is also presented (spectra a in panel A). Inset: detail of the spectral
changes in the 500–600 nm range. Similar spectral changeswere observedwith quercetin
and epicatechin (data not shown). Panel B shows the kinetics of reduction of cytochrome c
(20 μM) by epicatechin at different concentrations, followed at 550 nm. Complete reduc-
tion of cytochrome c was achieved with the addition of an excess of dithionite, a well-
known reductant of cytochrome c. All these reactions were performed in 10 mM potassi-
um phosphate buffer (pH 7.4), at 37 °C. The data shown are representative of the results
obtained in triplicate experiments. Panel C shows the dependence upon the concentration
of ﬂavonoids of the extent of reduction of cytochrome c. Flavonoids were added to 20 μM
oxidized cytochrome c in 10 mMpotassium phosphate buffer (pH 7.4). Reduction of cyto-
chrome cwasmonitored at 550 nm until equilibriumwas achieved at 37 °C. Complete re-
duction of cytochrome cwas obtainedwith the addition of an excess of dithionite. Results
are the mean±standard error from triplicate measurements.4. Discussion
The results of this study have pointed out that different ﬂavonoids
can produce distinct effects on the rate of production of H2O2 by
respiring mitochondria. Up to 10 μM concentration of ﬂavonoid quer-
cetin, kaempferol and epicatechin were found to elicit a signiﬁcant in-
hibition, whereas 2 ﬂavonoids (apigenin and naringenin) had no
statistically signiﬁcant effect on the rate of H2O2 production by
respiring brain and heart mitochondria. Among the ﬂavonoids
studied in this work, kaempferol and quercetin were the most potent
as inhibitors of the rate of H2O2 production by brain mitochondria
leading to nearly 100% inhibition with 10 μM ﬂavonoid, and showed
IC50 values of 0.9 and 1.8 μM, respectively. Also, this inhibition cannot
be simply due to a direct chemical reduction of produced H2O2 for
two major reasons: (i) these concentrations of ﬂavonoid did not
produce a signiﬁcant decrease of the Amplex Red ﬂuorescence signal
when added before this reagent to respiration buffer supplemented
with nanomolar H2O2 concentrations, and (ii) the inhibitory effect
of the ﬂavonoid was steady and lasted for at least 30 min. However,
this inhibition is not due to a signiﬁcant slowdown of the oxygen
consumption rate in respiring mitochondria, as up to 10 μM kaemp-
ferol and quercetin did not signiﬁcantly affect the oxygen consumption
rate. These results are consistent with previous reports showing lack of
inhibition of succinate-driven oxygen consumption by mitochondria in
the presence of 10 μM kaempferol or quercetin [47], as well as with the
lack of effect of other ﬂavonoids (taxifolin, catechin and galangin) on
mitochondrial respiration using both glutamate/malate and succinate
as substrates [42].Mitochondrial respiratory complexes I and III have been reported
to be the major systems involved in ROS production by respiring mi-
tochondria (reviewed in [2,9]). As micromolar concentrations of
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producing enzymes, such as lipoxygenases [67], xanthine oxidase
[68] and NADH and NADPH oxidases [52,69], we have experimentally
assessed that the inhibition afforded by kaempferol and quercetin on
the rate of H2O2 production by rat brain mitochondria was due to im-
pairment of ROS production by the main complexes of the respiratory
chain.
In the presence of the mitochondrial inhibitors rotenone and
antimycin A, production of H2O2 was stimulated, in accordance
with other studies [9,70]. Basal production of ROS by mitochondria
in normal conditions can have several sources as indicated above,
however, the increased production of O2− in the presence of rotenone
is known to come from complex I, while antimycin A exacerbates
ROS generation by complexes I and/or III [9,60,62]. Quercetin and
kaempferol showed similar potencies as inhibitors of H2O2 produc-
tion by mitochondria in basal and inhibitor-stimulated conditions,
which suggested that they inhibit complex I, and possibly also complex
III, ability to generate O2−. Indeed, we found that quercetin, kaempferol
and apigenin inhibit complex I (rotenone-sensitive NADH:CoQ1 oxido-
reductase) activity in brain sub-mitochondrial particles. However, our
results excluded the inhibition of the activity of complex II or of the
coupled activity of complexes II and III, leaving complex I as the major
target of quercetin and kaempferol for the inhibition of mitochondrial
ROS production.
With respect to quercetin and kaempferol, it is to be noted that
this conclusion is in good agreement with the results by Silva et al.
[47] who found that these compounds have no signiﬁcant effects
on succinate-supported respiration rate of brain mitochondria.
This conclusion is also consistent with recent results reported by
Filomeni et al. [49], who had shown that pre-treatment of HeLa
cells with 200 μM kaempferol inhibited malate/glutamate-supported
respiration, whereas no signiﬁcant effect was observed in succinate-
supported respiration, therefore suggesting that this ﬂavonoid affected
mitochondrial electron transfer chain at the level of complex I. Also
kaempferol has been reported to strongly attenuate rotenone-induced
oxidation of mitochondrial proteins in neuroblastoma cells [71].
The titration of the NADH:CoQ1 oxidoreductase activity of Com-
plex I of rat brain mitochondria shows that 50 μM quercetin and
kaempferol produced more than 50% inhibition, while below 10 μM
they afford only a weak inhibition, i.e. less than 20% of this activity.
Noteworthy, we found that the inhibition of complex I activity was
dependent on the concentration of CoQ present in the medium,
suggesting that the ﬂavonoids affect binding of the coenzyme substrate
to the complex. Complex I is known to have two distinct sites for qui-
nones reduction: the physiological, proton-translocating, inhibitor
(rotenone and piericidin A)-sensitive site, known as “hydrophobic
site”; and a non-energy-transducing, inhibitor-insensitive site, the
“hydrophilic site”. King et al. [72] presented strong evidence that
the “hydrophilic site” is located at the ﬂavin active site for NADH
oxidation. Recent data from different studies suggest that the
“hydrophobic site” is located in a quinone (and inhibitor) binding
pocket in a cavity between the PSST and the 49-kDa subunits, next to
iron–sulfur cluster N2 in the complex, as reviewed in [73]. Under the
conditions of our experiments, the ﬂow of electrons from NADH oxida-
tion is channeled through Complex I to the quinone in the “hydrophobic
site”, as shown by the almost complete (>90%) inhibition of the
activity by rotenone. Therefore, it is not probable that the inhibi-
tory effect of ﬂavonoids on NADH:CoQ1 oxidoreductase activity
occurs at the “hydrophilic” quinone reduction site.
Hydrophobic inhibitors bind to different but partially overlap-
ping binding sites within a large common binding domain in the
above cited quinone and inhibitor binding pocket, as it has been
pointed out by diverse and complementary experimental approaches
[73–75]. On these grounds, the differences in the extent of inhibition
of the NADH:CoQ1 oxidoreductase activity of Complex I produced by
the ﬂavonoids studied in this work (epicatechin, kaempferol,quercetin and apigenin), as well as the differences on the efﬁcien-
cy of protection by CoQ10 and CoQ1 against this inhibition, may
arise from different afﬁnities of these ﬂavonoids to these partially
overlapping sites or from different local conformational effects in
the inhibitor binding pocket of Complex I. The site(s) of reduction
of oxygen to produce superoxide anion in complex I remain unknown,
but the more probable candidates proposed are the ubisemiquinone
species, the ﬂavin and iron–sulfur cluster N2 [76,77]. Thus, our results
pointing out kinetic competition between coenzyme Q1 and the ﬂavo-
noids kaempferol and quercetin strongly suggest that these ﬂavonoids
bind to complex I in the quinone and inhibitor binding pocket as it
seems to happen with rotenone, despite that these ﬂavonoids and
rotenone showed opposed effects in H2O2 production by mitochon-
dria. In this regard, it is worth noting that among the different inhib-
itors of complex I, Fato et al. [77] found that some inhibitors induced
an increase in the production of ROS while others prevented the
same activity. These authors explained these observations on the
basis of a two-step mechanism of electron transfer to ubiquinone at
the active site, involving two distinct conformations differently
blocked by the inhibitors, being one of the conformations competent
for electron delivery to oxygen but not the other. In this sense, two
modes of action were also previously reported for different inhibitors
of complex I, all of which affected the electron transfer step from the
high potential iron-sulfur cluster to ubiquinone [78]. It is to be
recalled that pulse radiolysis studies yielded one-electron reduction
potentials close to 0.4 V for semiquinone radicals [79], a value that is
close to the reduction potential of ﬂavonoids kaempferol, quercetin
and epicatechin at pH 7.4, which lie between 0.3 and 0.4 V [80]. It
is to be noted that total H2O2 produced during our assays is well
below the IC50 values obtained in this work for these ﬂavonoids, i.e.
a nearly steady inhibition should be expected even if they act as
sacriﬁcial antioxidants. Indeed, the rate of H2O2 production by our
respiring mitochondria preparations is close to 0.2 nmoles H2O2/
min/mgmitochondrial protein, and this implies that during the aver-
age duration of our activity assays done with 0.1 mg mitochondrial
protein/ml in the presence of the ﬂavonoid (15 min) the total
production of H2O2 is ca. 0.3 nmoles/ml=0.3 μM H2O2. Thus, in situ
kinetic competition between the reactions of reduction of ﬂavonoids
and oxygen or alteration of the conformation of complex I competent
for electron delivery to oxygen due to the binding of the ﬂavonoid in
the hydrophobic pocket could provide the simplest hypothesis to ac-
count for the inhibition by ﬂavonoids of electron leakiness through
the semiubiquinone radical. A better three-dimensional resolution of
complex I conformations in the absence and presence of ﬂavonoids,
and also of their binding site(s) is needed to critically discriminate
between alternate possible molecular mechanisms for inhibition of
the NADH:CoQ1 oxidoreductase activity and superoxide anion produc-
tion by the ﬂavonoids.
There is a growing consensus that complex I is the major source of
O2− within mitochondria in vivo [9]. Complex I has been proposed to
be the initial site of ischemia-elicited damage to mitochondria in
the heart and the likely source of ROS in models of heart failure [1],
and deﬁciencies in complex I function are well documented in neuro-
degenerative diseases [2]. Therefore, the inhibition of complex I activ-
ity by concentrations of quercetin, kaempferol and apigenin in the
low micromolar range and, in accordance, the potent inhibition by
quercetin and kaempferol of H2O2 release by mitochondria may
have a high relevance in the context of prevention of neurodegenera-
tion and cardiovascular disease progression. Our results also point out
that coenzyme Q deﬁcient mitochondria should be more prone to
inhibition of complex I activity by these ﬂavonoids, due to the ob-
served competition between coenzyme Q and the ﬂavonoid. Despite
that ﬂavonoids can be more concentrated in mitochondria than in
other subcellular compartments [40,41], the concentrations of ﬂavo-
noids required to elicit a large inhibition of mitochondrial complex I
activity, i.e. above 10 μM, are more than 10-fold higher than those
Fig. 6. Effects of ﬂavonoids on mitochondrial production of hydrogen peroxide and modulation of respiratory chain components. (I): complex I; (II): complex II; (III): complex III;
(IV): complex IV; (c): cytochrome c; (cox): oxidized cytochrome c; (−): inhibition.
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epicatechin up to 100 μM only produced a weak inhibition of the
NADH:CoQ1 oxidoreductase activity of Complex I, less than 20% inhi-
bition, an inhibition which is much lower than the extent of observed
inhibition of the mitochondrial H2O2 production by this ﬂavonoid. It
is to be noted, however, that the rate of hydrogen peroxide produc-
tion by our respiring mitochondria preparations is 0.5–1% of their
rate of oxygen consumption, ca. 0.18–0.26 nmoles H2O2/min/mg mito-
chondrial protein versus nearly 50 ng atom O/min/mg mitochondrial
protein using pyruvate+malate as respiratory substrates.
In addition, our results have unraveled that one molecule of epica-
techin, kaempferol and quercetin can afford the reduction of two
molecules of puriﬁed cytochrome c at physiological pH, but not of
complex IV. The fact that half-reduction of 20 μM cytochrome c
takes place with concentrations of ﬂavonoid close to 5 μM points
out that this reaction has a high equilibrium constant value, and this
implies that it should be efﬁciently taking place at the low concentra-
tions of ﬂavonoids that can be attained in the brain after feeding or by
intraperitoneal or intravenous injections of moderate doses of ﬂavo-
noids, reviewed in the reference [39]. As the reported half-reduction
potentials of these ﬂavonoids in aqueous solution are higher than
the half-reduction potential of cytochrome c [80–82], these results
point out that binding of epicatechin, kaempferol and quercetin to
cytochrome c elicits either a large decrease of the half-reduction
potential of the ﬂavonoids or a signiﬁcant conformational change of
cytochrome c that increases the heme reduction potential or both.
The failure of apigenin to reduce cytochrome c is consistent with
this hypothesis, as the semireduction potential of apigenin in water,
0.86 V [83], is higher than those reported for epicatechin, kaempferol
and quercetin, ranging from 0.29 V to 0.43 V [80,82]. Owing to the key
role of oxidized cytochrome c in the early stages of cellular apoptosis,
reviewed in [84], this effect of ﬂavonoids is likely to contribute to the
observed protection of ﬂavonoids against the apoptosis-mediated cell
death [40,50]. Further work is required to assess the extent of
ﬂavonoid-induced reduction of cytochrome c bound to mitochondria,
as likely lipid-binding would interfere with the interaction of other
lipophilic molecules such as ﬂavonoids with cytochrome c.
4.1. Conclusions
The schematic diagram of Fig. 6 summarizes the major ﬁndings
reported in this work. Brieﬂy, different ﬂavonoids have distinct effects
on H2O2 production by brain and heart mitochondria, being quercetin
and kaempferol the most potent as inhibitors of H2O2 production
with IC50 values in the low micromolar range. For these ﬂavonoids
the major molecular targets of the mitochondrial respiratory chainunraveled by our study are complex I and cytochrome c. Both are
modulated by concentrations of the ﬂavonoids quercetin and kaemp-
ferol in the low micromolar range, i.e. by concentrations likely to be
attained in the brain in studies showing strong neuroprotection by
kaempferol against cerebral ischemia–reperfusion injury [85] and 3-
nitropropionic acid-induced neurodegeneration in the brain striatum
[18,86].
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